HYPERPHAGIA
Clinical trials for HYPERPHAGIA explained in plain language.
Never miss a new study
Get alerted when new HYPERPHAGIA trials appear
Sign up with your email to follow new studies for HYPERPHAGIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to curb hunger in Prader-Willi syndrome
Disease control OngoingThis phase 2 trial tests setmelanotide (Imcivree), a daily injection, in 18 people aged 6 to 65 with Prader-Willi syndrome who have obesity. The study will check if the drug is safe and helps reduce body weight and hunger over 52 weeks.
Matched conditions: HYPERPHAGIA
Phase: PHASE2 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Genetic clues to childhood obesity: study seeks answers
Knowledge-focused OngoingThis study looks at the genes of 1000 people with severe early-onset obesity to find rare genetic causes. It focuses on conditions like Bardet-Biedl syndrome. The goal is to better understand these conditions and improve how they are diagnosed. Participants provide a blood or sal…
Matched conditions: HYPERPHAGIA
Sponsor: Rolfs Consulting und Verwaltungs-GmbH (RCV) • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC